Recombinant Sminthopsis douglasi NADH-ubiquinone oxidoreductase chain 4L (MT-ND4L)

Shipped with Ice Packs
In Stock

Description

Recombinant Production

Expression System:

  • Produced in Escherichia coli with an N-terminal His-tag for purification .

  • Codon-optimized for bacterial expression to enhance yield .

Functional Studies:

  • Used to investigate mutations in Complex I subunits linked to metabolic disorders (e.g., Leber’s hereditary optic neuropathy) .

  • Enables in vitro analysis of electron transfer efficiency and proton-pumping mechanisms .

Comparative Biology:

  • Serves as a model for studying mitochondrial evolution in marsupials, given its divergence from placental mammalian homologs .

Therapeutic Development:

  • Potential tool for gene therapy targeting mitochondrial diseases, following strategies tested in human ND4 allotopic expression .

Challenges and Limitations

  • Stability Issues: Repeated freeze-thaw cycles degrade activity .

  • Species-Specificity: Limited cross-reactivity with antibodies raised against human ND4L due to sequence divergence .

Future Directions

  • Structural Studies: Cryo-EM or X-ray crystallography to resolve its role in Complex I assembly .

  • Gene Therapy: Adapting S. douglasi ND4L for mitochondrial transfection studies, inspired by success in human ND4 rescue experiments .

Product Specs

Form
Lyophilized powder
Please note: We prioritize shipping the format we currently have in stock. However, if you have a specific format requirement, please include this in your order notes. We will accommodate your request whenever possible.
Lead Time
Delivery times may vary depending on the purchasing method and location. Please consult your local distributors for specific delivery details.
Note: All proteins are shipped with standard blue ice packs. If you require dry ice shipping, please contact us in advance for arrangements and associated fees.
Notes
Repeated freezing and thawing is not recommended. Store working aliquots at 4°C for up to one week.
Reconstitution
We recommend briefly centrifuging the vial before opening to ensure the contents settle to the bottom. Reconstitute the protein in deionized sterile water to a concentration between 0.1-1.0 mg/mL. For long-term storage, we recommend adding 5-50% glycerol (final concentration) and aliquoting at -20°C/-80°C. Our default final concentration of glycerol is 50%, which can be used as a reference.
Shelf Life
Shelf life is influenced by various factors including storage conditions, buffer composition, storage temperature, and the inherent stability of the protein.
Generally, the shelf life of liquid form is 6 months at -20°C/-80°C. For lyophilized form, the shelf life is 12 months at -20°C/-80°C.
Storage Condition
Store at -20°C/-80°C upon receipt. Aliquoting is necessary for multiple uses. Avoid repeated freeze-thaw cycles.
Tag Info
Tag type is determined during the manufacturing process.
The tag type is determined during production. If you have a specific tag type requirement, please inform us, and we will prioritize developing the specified tag.
Synonyms
MT-ND4L; MTND4L; NADH4L; ND4L; NADH-ubiquinone oxidoreductase chain 4L; NADH dehydrogenase subunit 4L
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Expression Region
1-98
Protein Length
full length protein
Species
Sminthopsis douglasi (Julia creek dunnart)
Target Names
Target Protein Sequence
MLSINLNLIIAFLLALMGVLIYRSHLMSTLLCLEGMMLSLFILMTLLITHFHMFSMAMTP LILLVFSACEAAIGLALLVKISATHGSDHVQNLNLLQC
Uniprot No.

Target Background

Function
The core subunit of the mitochondrial membrane respiratory chain NADH dehydrogenase (Complex I) catalyzes electron transfer from NADH through the respiratory chain, using ubiquinone as an electron acceptor.
Protein Families
Complex I subunit 4L family
Subcellular Location
Mitochondrion inner membrane; Multi-pass membrane protein.

Q&A

What is Recombinant Sminthopsis douglasi NADH-ubiquinone oxidoreductase chain 4L (MT-ND4L)?

Recombinant Sminthopsis douglasi NADH-ubiquinone oxidoreductase chain 4L (MT-ND4L) is a protein encoded by the MT-ND4L gene. It functions as part of Complex I (NADH:ubiquinone oxidoreductase) in the mitochondrial respiratory chain. This protein plays a crucial role in the first step of the electron transport process, transferring electrons from NADH to ubiquinone during oxidative phosphorylation . The recombinant form is artificially produced for research purposes, with the protein derived from Sminthopsis douglasi (Julia Creek dunnart), a marsupial species .

How does MT-ND4L contribute to cellular energy production?

MT-ND4L functions as a subunit of Complex I, which is responsible for the initial step in the electron transport chain of oxidative phosphorylation. This process occurs within mitochondria, the cellular structures that convert energy from food into forms that cells can use. Specifically:

  • The protein participates in the transfer of electrons from NADH to ubiquinone .

  • This electron transfer helps create an unequal electrical charge (proton gradient) across the inner mitochondrial membrane .

  • The resulting electrochemical potential provides the energy necessary for ATP synthesis .

  • The process ultimately converts energy from nutrients into adenosine triphosphate (ATP), which serves as the cell's primary energy currency .

This fundamental biochemical process underlies virtually all cellular activities requiring energy.

How do mutations in MT-ND4L affect mitochondrial function and which disease states are associated with these mutations?

Mutations in the MT-ND4L gene can significantly impact mitochondrial function and are associated with specific disease states. The T10663C (Val65Ala) mutation has been identified in several families with Leber hereditary optic neuropathy (LHON) . This mutation changes a single amino acid in the protein, replacing valine with alanine at position 65.

The exact molecular mechanism by which this mutation leads to LHON remains incompletely understood, but likely involves:

  • Altered electron transport efficiency within Complex I

  • Increased production of reactive oxygen species

  • Compromised ATP generation

  • Selective vulnerability of retinal ganglion cells, particularly in the optic nerve

These pathophysiological changes ultimately result in the characteristic vision loss associated with LHON . Research into other potential disease associations continues, particularly regarding mitochondrial disorders with complex I deficiency.

What are the challenges in expressing and purifying recombinant MT-ND4L for structural studies?

Expressing and purifying recombinant MT-ND4L for structural studies presents several significant challenges:

  • Hydrophobicity: MT-ND4L is highly hydrophobic with multiple transmembrane domains, making it difficult to express in soluble form in conventional expression systems .

  • Conformational stability: Maintaining the native conformation of the protein outside its natural membrane environment is challenging. The protein may misfold or aggregate without proper membrane integration .

  • Expression yield: Being a mitochondrial protein, expression in bacterial systems may result in low yields due to differences in codon usage and post-translational modification machinery .

  • Purification complexity: Detergent-based extraction methods must be carefully optimized to maintain protein structure and function while removing contaminating proteins .

  • Conformational heterogeneity: The protein may adopt multiple conformations, complicating structural studies that require homogeneous samples .

To address these challenges, researchers typically employ specialized approaches such as:

  • Using fusion tags to enhance solubility

  • Optimizing detergent selection for membrane protein extraction

  • Employing lipid nanodiscs or other membrane mimetics

  • Utilizing advanced AI-driven conformational ensemble generation techniques to predict structure

  • Considering specialized expression systems for mitochondrial proteins

How does the redox potential of MT-ND4L impact electron transfer in Complex I?

The redox potential of MT-ND4L significantly influences electron transfer efficiency within Complex I. Research indicates that the negative charge of the nearby iron-sulfur cluster N2 can shift the midpoint potential of ubiquinone to approximately -300 mV, an unusually low value . This shift has profound implications:

  • It effectively equalizes the redox potential difference between NADH and ubiquinone molecules in binding site 1, rendering Q reduction isoenergetic .

  • The energetic benefit shifts to the movement of the reduced ubiquinone (QH₂) from site 1 to the exit of the Q tunnel, as a redox potential difference of approximately +90 mV exists between Q in site 1 and Q in the membrane .

  • This energy conversion step is hypothesized to involve the binding of QH₂ near the entry of the E channel (approximately site 4), which may "push" protons previously loaded on acidic ND1 residues, contributing to the proton pumping mechanism .

What are the optimal conditions for storing and handling recombinant Sminthopsis douglasi MT-ND4L?

Optimal storage and handling conditions for recombinant Sminthopsis douglasi MT-ND4L are critical for maintaining protein integrity and function:

Storage Conditions:

  • Store at -20°C for short-term storage

  • For extended storage, conserve at -20°C or -80°C

  • The protein is typically supplied in a Tris-based buffer with 50% glycerol, optimized specifically for this protein's stability

Handling Recommendations:

  • Avoid repeated freeze-thaw cycles as they can lead to protein degradation or aggregation

  • Prepare working aliquots and store at 4°C for up to one week to minimize freeze-thaw damage

  • When thawing, warm samples gently to room temperature rather than using heat

  • Handle the protein in buffers compatible with membrane proteins, potentially containing appropriate detergents or lipids

  • Minimize exposure to oxidizing conditions that could affect redox-sensitive residues

Following these guidelines helps ensure experimental reproducibility and maintains the structural and functional integrity of this challenging membrane protein.

What experimental approaches are most effective for studying MT-ND4L interactions with other Complex I components?

Several experimental approaches have proven effective for studying MT-ND4L interactions with other Complex I components:

1. Cryo-electron microscopy (cryo-EM):

  • Allows visualization of the entire Complex I structure including MT-ND4L in near-native conditions

  • Can reveal conformational changes under different functional states

  • Provides insights into the spatial arrangement of MT-ND4L relative to other subunits

2. Crosslinking mass spectrometry:

  • Identifies points of contact between MT-ND4L and neighboring subunits

  • Covalent crosslinks can capture transient interactions during the catalytic cycle

  • Mass spectrometric analysis pinpoints specific residues involved in subunit interactions

3. AI-enhanced molecular dynamics simulations:

  • Predicts alternative functional states of MT-ND4L

  • Explores conformational changes along collective coordinates

  • Identifies representative structures through trajectory clustering

  • Generates statistically robust ensembles of equilibrium protein conformations

4. Site-directed mutagenesis combined with functional assays:

  • Introduces specific mutations at predicted interaction sites

  • Assesses effects on complex assembly, stability, and activity

  • Can validate computational predictions about critical interaction residues

5. Binding pocket identification and characterization:

  • AI-based pocket prediction modules discover orthosteric, allosteric, hidden, and cryptic binding pockets

  • Integrates structure-aware ensemble-based detection algorithms with protein dynamics data

  • Helps identify potential sites for probe binding or drug targeting

These complementary approaches provide a comprehensive understanding of how MT-ND4L interacts with other Complex I components to facilitate electron transport and energy conversion.

What techniques can be used to measure the catalytic activity of recombinant MT-ND4L in vitro?

Measuring the catalytic activity of recombinant MT-ND4L presents unique challenges since it functions as part of the larger Complex I. Several techniques can be employed:

1. Reconstitution into proteoliposomes:

  • Integrate purified MT-ND4L with other Complex I components in artificial lipid bilayers

  • Measure NADH:ubiquinone oxidoreductase activity using spectrophotometric assays

  • Monitor NADH oxidation by following absorbance decrease at 340 nm

2. Oxygen consumption measurements:

  • Use oxygen electrodes (Clark-type) to measure respiration rates

  • Assess the impact of MT-ND4L mutations or modifications on electron transport efficiency

  • Can be performed with isolated mitochondria or reconstituted systems

3. Transhydrogenation assays:

  • Evaluate the specificity of Complex I for NADH versus NADPH

  • Measure the rate of hydride transfer between nucleotides

  • Can reveal functional alterations in MT-ND4L that affect nucleotide binding specificity

The following table summarizes typical parameters for Complex I activity measurements:

ParameterNADH OxidationNADPH OxidationTranshydrogenation
Km (NADH)5-15 μM-5-15 μM
Km (NADPH)-180-250 μM180-250 μM
Km (Q)10-40 μM10-40 μM-
Km (NAD+)--200-350 μM
Vmax (relative)100%<0.2%Minimal under physiological conditions

Note that the strong specificity of Complex I for NADH (rather than NADPH) is the predominant mechanism preventing significant transhydrogenation . When studying MT-ND4L specifically, mutations or modifications that alter these kinetic parameters can provide insights into its role within the complex.

How can AI-driven approaches enhance structural and functional studies of MT-ND4L?

AI-driven approaches have revolutionized the study of challenging proteins like MT-ND4L by providing insights that traditional experimental methods alone cannot achieve:

1. LLM-powered literature research:

  • Custom-tailored language learning models can extract and formalize information about MT-ND4L from diverse structured and unstructured data sources

  • Information can be organized into knowledge graphs capturing therapeutic significance, small molecule interactions, off-targets, and protein-protein interactions

  • This comprehensive analysis accelerates research by integrating disparate information sources

2. AI-Driven Conformational Ensemble Generation:

  • Advanced AI algorithms predict alternative functional states of MT-ND4L, including large-scale conformational changes

  • Molecular simulations with AI-enhanced sampling explore the conformational space of the protein

  • Diffusion-based AI models and active learning AutoML generate statistically robust ensembles of equilibrium protein conformations

  • These ensembles provide a foundation for accurate structure-based drug design and mechanistic studies

3. Binding pocket identification and characterization:

  • AI-based pocket prediction modules discover orthosteric, allosteric, hidden, and cryptic binding pockets on the protein's surface

  • Integration of literature search data with structure-aware ensemble-based pocket detection algorithms enhances discovery power

  • AI scoring and ranking of tentative pockets identifies the most promising targets for further investigation

These AI-driven approaches complement traditional experimental methods, providing structural and functional insights that would be difficult or impossible to obtain through experimental approaches alone, particularly for membrane proteins like MT-ND4L.

What is the evolutionary significance of MT-ND4L conservation across species?

The evolutionary conservation of MT-ND4L across diverse species points to its fundamental importance in cellular energetics:

  • Mitochondrial origin: MT-ND4L is encoded by mitochondrial DNA, reflecting its ancient bacterial origin through endosymbiosis. Its conservation provides insights into the evolution of energy metabolism in eukaryotes.

  • Functional constraints: The high degree of sequence conservation in key functional regions suggests strong selective pressure to maintain electron transport efficiency.

  • Species adaptations: Variations in MT-ND4L sequences across species may reflect adaptations to different metabolic demands and environmental conditions. For example, the Sminthopsis douglasi variant may contain adaptations related to the unique metabolic requirements of this marsupial species .

  • Disease-associated mutations: The association of specific mutations with conditions like Leber hereditary optic neuropathy highlights the functional importance of conserved residues and how their alteration can lead to pathology .

  • Co-evolution patterns: MT-ND4L likely exhibits co-evolutionary patterns with other Complex I components, reflecting the need for coordinated function within this multi-subunit enzyme complex.

Comparative analysis of MT-ND4L across species can provide insights into both fundamental aspects of mitochondrial function and species-specific adaptations in energy metabolism.

What are the key knowledge gaps and future research priorities for MT-ND4L studies?

Despite significant advances in our understanding of MT-ND4L, several important knowledge gaps remain, creating opportunities for future research:

1. Structure-function relationships:

  • Determining high-resolution structures of MT-ND4L in different functional states

  • Understanding how specific amino acid residues contribute to electron transfer and proton pumping

  • Elucidating the dynamic conformational changes that occur during catalysis

2. Disease mechanisms:

  • Clarifying how MT-ND4L mutations lead to Leber hereditary optic neuropathy at the molecular level

  • Investigating the potential role of MT-ND4L variants in other mitochondrial disorders

  • Developing therapeutic approaches targeting MT-ND4L dysfunction

3. Species-specific adaptations:

  • Comparative studies of MT-ND4L across diverse species, including Sminthopsis douglasi

  • Understanding how evolutionary adaptations in MT-ND4L contribute to metabolic differences

  • Exploring the functional significance of unique sequence features in marsupial MT-ND4L variants

4. Interaction with pharmacological agents:

  • Identifying compounds that can modulate MT-ND4L function

  • Exploring the potential of MT-ND4L as a drug target for mitochondrial diseases

  • Understanding how environmental toxins might affect MT-ND4L function

5. Methodological advancements:

  • Developing improved techniques for recombinant expression and purification

  • Creating better assays for measuring MT-ND4L function in isolation and within Complex I

  • Refining AI-based approaches to predict structure, dynamics, and interactions

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.